Skip to content

Clinical trials

Cerebrovascular Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cerebrovascular Disorders Country / region: United States Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20031
20041
20062
20073
20087
20093
20101
20114
20125
20134
20143
20155
20166
20174
20188
20193
20202
20212
20224
20232
20245
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Recruiting16
Terminated11
Active, not recruiting10
Unknown status5
Withdrawn3
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)8
Magnetic Tides3
National Heart, Lung, and Blood Institute (NHLBI)3
University of Wisconsin, Madison3
VA Office of Research and Development3
Beth Israel Deaconess Medical Center2
Centre hospitalier de l'Université de Montréal (CHUM)2
Mayo Clinic2
Microvention-Terumo, Inc.2
National Institute on Aging (NIA)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cerebrovascular Disorders96
Stroke53
Brain Diseases26
Cardiovascular Diseases23
Central Nervous System Diseases22
Vascular Diseases22
Nervous System Diseases19
Ischemic Stroke17
Brain Ischemia12
Brain Infarction9

Trials

Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.